Found 19 matching trials
Lot Consistency Clinical Trial of of Recombinant HPV Bivalent Vaccine in 9 to14 Years Old Healthy Female PHASE4 This study is to evaluate lot-lot consistency of Recombinant Human Papillom...
Show More Location
Dongtai City Center for Disease Control and Prevention Dongtai, Jiangsu
Learn More & Join Trial
Comparing Health Services Interventions for the Prevention of HPV-related Cancer PHASE4 The study aims to identify global and local determinants of HPV vaccine acc...
Show More Learn More & Join Trial
Evaluation of Safety and Immunogenicity of Co-administering Human Papillomavirus (HPV) Vaccine With Other Vaccines in Healthy Female Subjects PHASE3 Infection with human papillomavirus (HPV) has been clearly established as t...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Evaluation of Safety of a Vaccine Against Cervical Cancer in Healthy Korean Females N/A This Post Marketing Surveillance (PMS) will collect safety data on the use ...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Drug Use Investigation for Cervarix® N/A This post-marketing study was designed to assess safety and efficacy of Cer...
Show More Location
Multiple Locations
Learn More & Join Trial
Effectiveness of Single Dose or Two Doses of Bivalent HPV Vaccine in Thailand NA This is a community intervention effectiveness study in female school stude...
Show More Location
Ministry of Public Health
Learn More & Join Trial
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus Vaccine (Cervarix™) When Co-administered With GSK Biologicals' Hepatitis A Vaccine (Havrix®) in Healthy Female Adolescents Aged 9-14 Years PHASE3 The purpose of this study is to evaluate the immunogenicity and safety of t...
Show More Location
Multiple Locations
Learn More & Join Trial
Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Cervarix® PHASE3 The aim of this study was to investigate the immunogenicity and safety of C...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of the Molecular Mechanisms Underlying the Cross-neutralizing Capacity of AS04-adjuvanted HPV Vaccine (Cervarix®) in Comparison With the Aluminiumhydroxyphosphate Sulphate Adjuvanted HPV Vaccine (Gardasil®) PHASE4 Six identical female twins aged 9-13 years will participate. One sib of eac...
Show More Location
Ghent University Hospital
Learn More & Join Trial
Evaluation of Safety and Immunogenicity of Co-administering HPV Vaccine With Other Vaccines in Healthy Female Subjects PHASE3 Infection with human papillomavirus (HPV) has been clearly established as t...
Show More Location
GSK Investigational Site
Learn More & Join Trial